Chemoinformatics study of HDAC3 and HDAC6 inhibitors
The potential of integrated computational approaches to guide the rational design of selective HDAC inhibitors for future epigenetic therapies is demonstrated, and distinct structure-activity relationships between the two isoforms are revealed.